scPharmaceuticals Inc. provided revenue guidance for the full year 2023. For the period, the company anticipates net revenue to be in a range of $13.4 million to $13.6 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.49 USD | +3.22% | -1.54% | -28.39% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.39% | 162M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- SCPH Stock
- News scPharmaceuticals Inc.
- ScPharmaceuticals Inc. Provides Revenue Guidance for the Full Year 2023